Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
The SpaceX mission
A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station. Slideshow
U.S. panel backs Merck HPV vaccine for males
A nurse administers a shot of gardasil to a 14-year old patient in Dallas, March 6, 2007.
Credit: Reuters/Jessica Rinaldi
GAITHERSBURG, Maryland |
GAITHERSBURG, Maryland (Reuters) - Merck & Co's cervical cancer vaccine is safe and effective for preventing genital warts in males ages 9 to 26, a U.S. advisory panel said on Wednesday.
The Gardasil vaccine has already been approved for girls and young women to prevent infection with the sexually transmitted human papillomavirus (HPV), which causes cervical cancer and genital warts.
A Food and Drug Administration (FDA) advisory panel voted 7-1 that Gardasil was safe for males. Seven panelists also said Merck's data showed the shot was effective, with one panel member abstaining from a vote.
Merck shares closed up 58 cents at $31.55 on Wednesday.
(Reporting by Lisa Richwine)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters